NYXH

Nyxoah SA

0.8220

Oct 22 • 3:59 PM ET -0.0730 (-8.16%)

0.8400

Aftermarket • 7:30 PM ET +0.0180 (2.19%)

Healthcare Medical Devices Belgium Micro NASD

Peers: INSP LIVN CVRX NPCE ECOR STIM RMD BWAY INGN VVOS

Scroll to Statements

Index	-
Market Cap	83.71M
Enterprise Value	40.49M
Income	-111.90M
Sales	25.25M
Book/sh	0.95
Cash/sh	1.10
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	Apr 28, 2021

P/E	-
Forward P/E	-
PEG	-
P/S	3.32
P/B	0.87
P/C	0.75
P/FCF	-
EV/EBITDA	-
EV/Sales	1.60
Quick Ratio	2.29
Current Ratio	2.37
Debt/Eq	0.72
LT Debt/Eq	0.44
Option/Short	No / Yes

EPS (ttm)	-2.52
EPS next Y	-0.81
EPS next Q	-0.35
EPS this Y	52.23%
EPS next Y	37.68%
EPS next 5Y	43.23%
EPS past 3/5Y	-28.04% -28.17%
Sales past 3/5Y	51.67% 170.10%
EPS Y/Y TTM	-9.99%
Sales Y/Y TTM	369.67%
EPS Q/Q	-7.74%
Sales Q/Q	487.55%
Earnings	Aug 05 AMC
EPS/Sales Surpr.	-48.92% 1.30%

Insider Own	19.83%
Insider Trans	0.00%
Inst Own	23.70%
Inst Trans	17.50%
ROA	-67.96%
ROE	-123.53%
ROIC	-81.97%
Gross Margin	30.34%
Oper. Margin	-393.88%
Profit Margin	-443.15%
SMA20	-34.76%
SMA50	-42.71%
SMA200	-68.69%
Trades

Shs Outstand	100.07M
Shs Float	81.64M
Short Float	0.39%
Short Ratio	1.13
Short Interest	0.32M
52W High	5.96 -86.21%
52W Low	0.88 -6.44%
Volatility	7.06% 5.37%
ATR (14)	0.08
RSI (14)	21.67
Beta	1.75
Rel Volume	2.26
Avg Volume	285.00K
Volume	643,750

Perf Week	-30.92%
Perf Month	-38.20%
Perf Quarter	-41.29%
Perf Half Y	-73.14%
Perf YTD	-82.13%
Perf Year	-85.70%
Perf 3Y	-86.57%
Perf 5Y	-96.40%
Perf 10Y	-
Recom	1.86
Target Price	3.90
Prev Close	0.89
Price	0.82
Change %	-8.16%

Date	Action	Analyst	Rating Change	Price Target Change
May-12-26	Downgrade	Stifel	Buy → Hold	$5
Jul-31-23	Initiated	H.C. Wainwright	Buy
Jul-19-23	Initiated	Robert W. Baird	Neutral
Apr-21-22	Initiated	Oppenheimer	Outperform	$30
Apr-06-22	Initiated	Wolfe Research	Peer Perform	$21
Dec-21-21	Resumed	Cantor Fitzgerald	Overweight	$47
Jul-28-21	Initiated	Cantor Fitzgerald	Overweight	$43

Oct-19-26 08:00AM	Nyxoah Announces Preliminary Results for the Third Quarter of 2026 and Adjusts Revenue Guidance for 2026 (GlobeNewswire) -14.05%
Oct-15-26 04:05PM	Full 12-Month Data from the ACCCESS U.S. Pivotal Study in Complete Concentric Collapse Patients Presented at ISSS 2026 (GlobeNewswire) -6.72%
Sep-28-26 04:30PM	Nyxoah Appoints Liam Kelly as Chief Executive Officer (GlobeNewswire) +9.66% -13.84%
Sep-23-26 10:00AM	CVRx names John Landry as CFO (MedTech Dive)
Sep-21-26 04:01PM	Nyxoah Announces Chief Financial Officer Transition (GlobeNewswire) -5.41%
04:05PM	Loading…
Sep-07-26 04:05PM	Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio System (GlobeNewswire)
Sep-02-26 04:05PM	Nyxoah Announces ACCCESS U.S. Pivotal Study Meets Primary Safety and Efficacy Endpoints in Complete Concentric Collapse Patients (GlobeNewswire) +16.56%
Aug-25-26 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire)
Aug-06-26 01:07AM	Nyxoah SA (NYXH) (Q2 2026) Earnings Call Highlights: US Revenue Surges 22% Sequentially, $110M ... (GuruFocus.com) -7.09%
Aug-05-26 04:05PM	Nyxoah Reports Second Quarter and First Half 2026 Financial and Operating Results (GlobeNewswire)
Aug-04-26 09:50AM	Earnings To Watch: Nyxoah SA (XBRU:NYXH) Q2 2026 -- GF Value Sees 5209% Upside (GuruFocus.com)
Jul-27-26 04:05PM	Nyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026 (GlobeNewswire)
Jul-07-26 04:05PM	Nyxoah Announces Preliminary Results for the Second Quarter of 2026 (GlobeNewswire) -5.08%
Jun-30-26 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire) +5.33%
Jun-29-26 04:30PM	Publication relating to transparency notifications (GlobeNewswire)
04:05PM	Loading…
Jun-23-26 04:05PM	Nyxoah to Host Investor Day in New York on July 8, 2026 (GlobeNewswire)
Jun-19-26 04:30PM	Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 9, 2026 (GlobeNewswire)
Jun-17-26 04:30PM	Publication relating to transparency notifications (GlobeNewswire)
04:05PM	Nyxoah Receives $15 Million from the European Investment Bank (GlobeNewswire)
Jun-15-26 04:05PM	Nyxoah's Genio Wins Prix Galien UK 2026 Award for Best Medical Technology (GlobeNewswire) +11.51%
Jun-10-26 05:00PM	Information on the total number of voting rights and shares (GlobeNewswire) +13.74%
04:30PM	$110 Million in Aggregate Financings to Accelerate Genio's U.S. Commercial Launch (GlobeNewswire)
04:05PM	Nyxoah Announces Closing of Underwritten Public Offering (GlobeNewswire)
Jun-05-26 12:58PM	Why Is NYXH Stock Falling Today? (Stocktwits) -49.65%
11:25AM	Nyxoah Announces Pricing of $95 Million Underwritten Public Offering (GlobeNewswire)
Jun-04-26 04:02PM	Nyxoah Announces Proposed Offering of Ordinary Shares (GlobeNewswire)
04:01PM	Nyxoah Enters New Chapter of Long Term Value Creation (GlobeNewswire)
May-20-26 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire)
04:05PM	Nyxoah Welcomes the Flemish Investors Federation (VFB) at LegiaPark following Q1 2026 Results and U.S. Commercial Momentum (GlobeNewswire)
May-13-26 01:01AM	Nyxoah SA (NYXH) Q1 2026 Earnings Call Highlights: Strong U.S. ... (GuruFocus.com)
04:05PM	Loading…
May-12-26 04:05PM	Nyxoah Reports First Quarter 2026 Financial and Operating Results (GlobeNewswire) -7.81%
May-11-26 09:22AM	Nyxoah SA (XBRU:NYXH) Q1 2026 Earnings Report Preview: What To Expect (GuruFocus.com)
May-08-26 04:05PM	Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 10, 2026 (GlobeNewswire)
Apr-30-26 04:05PM	Nyxoah to Participate in the Bank of America 2026 Healthcare Conference (GlobeNewswire)
Apr-28-26 04:05PM	Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026 (GlobeNewswire)
Mar-20-26 05:30PM	Publication relating to transparency notifications (GlobeNewswire)
01:00AM	Nyxoah SA (NYXH) Q4 2025 Earnings Call Highlights: U.S. Launch Success and Financial Challenges (GuruFocus.com)
Mar-19-26 04:10PM	Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating Results (GlobeNewswire)
Mar-18-26 09:22AM	Earnings To Watch: Nyxoah SA (XBRU:NYXH) Reports Q4 2025 Result (GuruFocus.com)
Mar-13-26 05:30PM	Publication relating to transparency notification (GlobeNewswire) -8.99%
Mar-11-26 05:05PM	Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference (GlobeNewswire)
Mar-05-26 04:05PM	Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026 (GlobeNewswire) -5.58%
Mar-04-26 05:55PM	Veeva Systems (VEEV) Q4 Earnings and Revenues Surpass Estimates (Zacks) +5.07%
Feb-27-26 04:30PM	Publication relating to transparency notifications (GlobeNewswire) -13.19%
Feb-25-26 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire) +5.62%
Feb-18-26 04:05PM	Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East (GlobeNewswire) +8.69%
Jan-21-26 04:05PM	Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth (GlobeNewswire)
Jan-12-26 04:05PM	Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2025 and Provides Revenue Guidance for the First Quarter of 2026 (GlobeNewswire)
01:00AM	Publication relating to transparency notification (GlobeNewswire)
Dec-29-25 04:05PM	Nyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +6.26%
Dec-19-25 04:05PM	Nyxoah Announces Issuance of First Tranche of Convertible Bonds (GlobeNewswire)
Dec-17-25 01:05AM	Nyxoah Announces Commercial Launch of Genio Breakthrough Therapy in the Netherlands (GlobeNewswire)
Dec-02-25 04:30PM	Publication relating to transparency notifications (GlobeNewswire) -5.42%
Dec-01-25 09:14AM	Nyxoah Gains Favorable CMS Reimbursement Ruling for Genio System (Zacks)
Nov-27-25 04:05PM	Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire)
Nov-26-25 01:45AM	Nyxoah's Genio Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule (GlobeNewswire)
Nov-23-25 08:00PM	Nyxoah SA (NYXH) Q3 2025 Earnings Call Highlights: Strong US Launch and Strategic Expansion ... (GuruFocus.com)
Nov-20-25 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire)
Nov-13-25 07:30PM	Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio (GlobeNewswire) -9.85% -5.84%
05:55PM	Nyxoah SA (NYXH) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
04:12PM	Nyxoah Reports Third Quarter 2025 Financial and Operating Results (GlobeNewswire)
Nov-12-25 07:30AM	Nyxoah SA (XBRU:NYXH) Q3 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Nov-06-25 07:15AM	Enovis (ENOV) Q3 Earnings and Revenues Beat Estimates (Zacks)
Nov-03-25 04:05PM	Nyxoah to Participate in the Stifel 2025 Healthcare Conference (GlobeNewswire)
Oct-30-25 05:10PM	Nyxoah to Release Third Quarter 2025 Financial Results on November 13, 2025 (GlobeNewswire)
10:00AM	10x Genomics (TXG) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
Oct-29-25 10:00AM	Analysts Estimate Nyxoah SA (NYXH) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-07-25 12:30PM	Nyxoah Shares Rise on First U.S. Commercial Use of Genio System (Zacks) +12.41%
Oct-06-25 01:00AM	Nyxoah Announces First U.S. Commercial Patients Implanted with Genio System (GlobeNewswire) +17.17%
Oct-03-25 04:30PM	Publication relating to transparency notifications (GlobeNewswire)
Oct-02-25 09:10AM	Nyxoah Expands in the Middle East to Provide Wider Access to Genio (Zacks)
Sep-23-25 04:10PM	Nyxoah Provides an Update on Expanded Middle East Presence (GlobeNewswire)
Sep-15-25 04:10PM	Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc. (GlobeNewswire) -8.97%
Sep-05-25 04:30PM	Publication relating to transparency notifications (GlobeNewswire)
Sep-02-25 04:30PM	Nyxoah Announces Upcoming Investor Events (GlobeNewswire) -5.45%
Aug-29-25 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire)
Aug-18-25 04:10PM	Nyxoah Reports Second Quarter Financial and Operating Results (GlobeNewswire) +5.63%
Aug-15-25 10:10AM	Nyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea (Zacks) -8.53%
09:18AM	Nyxoah SA (NYXH) Q2 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Aug-11-25 07:00PM	Standard BioTools (LAB) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -5.39%
01:00AM	Nyxoah Announces Preliminary Results for the Second Quarter of 2025 (GlobeNewswire)
Aug-08-25 04:10PM	Nyxoah Receives Approval from FDA for Genio System for the Treatment of Obstructive Sleep Apnea (GlobeNewswire)
Aug-07-25 07:10AM	Privia Health (PRVA) Misses Q2 Earnings Estimates (Zacks)
Aug-06-25 05:55PM	Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
Jul-29-25 04:45PM	Information on the total number of voting rights and shares (GlobeNewswire)
04:30PM	Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025 (GlobeNewswire)
Jul-28-25 04:05PM	Nyxoah's DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine (GlobeNewswire) -5.41%
Jun-27-25 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire)
Jun-13-25 01:00AM	Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 2, 2025 (GlobeNewswire)
May-30-25 04:30PM	Publication relating to transparency notifications (GlobeNewswire)
May-28-25 04:30PM	Nyxoah to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
May-23-25 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire) -6.97%
May-14-25 07:35AM	Nyxoah SA (NYXH) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
01:00AM	Nyxoah Reports First Quarter Financial and Operating Results (GlobeNewswire)
May-09-25 04:30PM	Publication relating to transparency notifications (GlobeNewswire) -5.08%
01:00AM	Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 11, 2025 (GlobeNewswire)
May-08-25 07:15AM	Claritev Corporation (CTEV) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-07-25 05:15PM	Health Catalyst (HCAT) Q1 Earnings Meet Estimates (Zacks)
04:30PM	Nyxoah to Release First Quarter 2025 Financial Results on May 14, 2025 (GlobeNewswire)
May-06-25 05:55PM	Clover Health Investments, Corp. (CLOV) Surpasses Q1 Earnings Estimates (Zacks)

Show Previous News

Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. The company was founded by Robert Taub and Adi Mashiach on July 15, 2009, and is headquartered in Mont-Saint-Guibert, Belgium.

Co-Founder & ChairmanMr. Robert Taub MBA

Chief Technical OfficerMr. Bruno Onkelinx

Chief Executive OfficerMr. Liam J. Kelly

President of International & Interim CFOMr. Loic Moreau

Chief Science OfficerMr. Jeyakumar Subbaroyan

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NYXH

Nyxoah SA

Upgrade your Finviz experience